RecruitingNCT04927650

Prevention and Early Detection of Cervical Cancer Through Self-Administered Screening

Prevention and Early Detection of Cervical Cancer Through Self-Administered Screening in the Community


Sponsor

University of California, San Francisco

Enrollment

3,200 participants

Start Date

Jan 8, 2015

Study Type

OBSERVATIONAL

Conditions

Summary

This study examines prevention and early detection of cervical cancer through self-administration screening of patients in Western Uganda. The cervix is the opening of the uterus or womb, which is the organ that supports babies before they are born. There are simple tests that let doctors know whether or not patients have cells that may become cancer. Some of the tests determine whether patients have an increased risk for cervical disease, but they do not actually confirm that they have it: these are called "screening" tests. This study may help researchers determine how to best deliver cervical cancer prevention services using the HPV test.


Eligibility

Sex: FEMALEMin Age: 25 YearsMax Age: 49 Years

Inclusion Criteria4

  • Women in the three Ugandan districts (Kiboga, Kyankwanzi and Hoima) who access screening during the community health campaigns
  • Age 25-49 years
  • Resident in the study district
  • Provision of informed consent

Exclusion Criteria1

  • Clinical signs and symptoms of cancer of the cervix

Interventions

DIAGNOSTIC_TESTHPV testing

Undergo collection of cervical samples for HPV testing

OTHERQuestionnaire Administration

Complete questionnaires


Locations(1)

Makerere University College of Health Sciences School of Medicine

Kampala, Uganda

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04927650


Related Trials